Design, Molecular Docking, Synthesis, Characterization and Preliminary Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Cyclin-Dependent Kinase 2 Inhibitors. AJPS. 2025;25(1):94-109. doi:10.32947/ajps.v25i1.1132